Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000529542 | SCV000649763 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2024-03-16 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln118Leufs*95) in the SGCA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SGCA are known to be pathogenic (PMID: 9192266). This variant is present in population databases (rs752640127, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with SGCA-related conditions (PMID: 9032047). This variant is also known as "duplication of 347-351". ClinVar contains an entry for this variant (Variation ID: 471332). For these reasons, this variant has been classified as Pathogenic. |
Clinical Genetics and Genomics, |
RCV001269775 | SCV001450030 | pathogenic | not provided | 2018-11-20 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000529542 | SCV003931660 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000529542 | SCV004203189 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2024-03-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000529542 | SCV005649534 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2024-06-06 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000529542 | SCV002087560 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2020-07-03 | no assertion criteria provided | clinical testing |